Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Lipid Disorders
Sebelipase Alfa Normalizes ALT and Multiple other Disease-Related Abnormalities in Patients with LAL-D
High Fatty Acids and Low Fiber Intake is Associated with CRC
ODYSSEY COMBO II: Alirocumab Significantly Improves Cholesterol Levels in Patients with High CV Risk
ODYSSEY FH I and FH II: Alirocumab Significantly Improves Cholesterol Levels in Patients with HeFH
COPD Exacerbations Not Prevented with Simvastatin in STATSCOPE Study
New Guidelines for Hypertension with Comorbidities
Ratio of Total Cholesterol to HDL-C is a More Relevant CV Risk Marker in T1DM
ACC/AHA Guideline for Blood Cholesterol: Appropriate for Patients with Diabetes?
Monoclonal Antibody Reduces LDL-C in Presence of Statin (LAPLACE-2)
PCSK9 Inhibitor Slashes LDL-C in Statin-Intolerant Patients (GAUSS-2)
Pages
Next
1
2
3
4